Session PP-02 No nonsense: When a premature termination is not what it appears Poster Abstract Marcy Richardson, Nelly Abualkheir, Elizabeth Chao, Jamie Weyandt, PhD, Colin Young, PhD
Session PP-10 Biallelic variants in NTHL1 and MSH3 in individuals ascertained from a multigene panel testing (MGPT) cohort: A descriptive analysis Abstract Poster Jennifer Herrera-Mullar
Session PP-01 Truncating variants in 5’ exons of APC are associated with highly attenuated phenotypes and emphasize the need for genotype-phenotype correlation Poster Abstract Jamie Weyandt, PhD
Session Presidential Plenary Session I Utility of RNA testing in individuals at increased risk for hereditary or familial pancreatic cancer Abstract Beth Dudley
Session Plenary Session I (Abstract 126) Disparities in the uptake of cascade genetic testing among family members of mutation-positive Lynch and HBOC syndrome patients Elia Namey
Session Plenary Session I (Abstract TBD) Inherited cancer susceptibility gene mutations among patients with appendix cancer Andreana Holowatyi
Session Presidential Plenary Session I CTNNA1 germline variants associate with a disease spectrum extending beyond Hereditary Diffuse Gastric Cancer Abstract Silvana Lobo
Session Sponsored Lunch Industry Session From bench to clinical report: Application of RNA and functional MAVEs to reduce VUS and improve positive yield of genetic testing Rachid Karam PhD., Executive Director, Clinical & Translation Research, Ambry Genetics, Anthony Scott, MD, PhD, Clinical Assistant Professor of Internal Medicine, Division of Genetic Medicine, University of Michigan Medical School
Session Oral Session V (Abstract 79) A deep dive into APC introns: Paired DNA/RNA testing identifies novel FAP and AFAP alleles in the deep intronic regions of APC Abstract Colin Young